Clinical Trials Directory

Trials / Sponsors / David Rizzieri, MD

David Rizzieri, MD

Academic / Other · 9 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnPhase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant
Hodgkin Lymphoma, Non-Hodgkin Lymphoma
Phase 22016-12-01
CompletedLenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)
Leukemia, Lymphocytic, Chronic, B-Cell
Phase 12012-01-01
CompletedEfficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant
Hodgkin's Disease, Non Hodgkin's Lymphoma, Myeloma
Phase 22008-02-01
TerminatedPTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma
Lymphoma, Large-Cell, Diffuse
Phase 22005-11-01
CompletedSafety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT
Lymphoma
Phase 12005-05-01
CompletedAllo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath
Lymphoma, Myeloma, Leukemia
Phase 22005-05-01
CompletedSafety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT
Lymphoma
Phase 12005-04-01
CompletedAllo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath
Lymphoma, Myeloma, Leukemia
Phase 22003-02-01
CompletedAllogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syn
Sickle Cell Anemia, Severe Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 21999-09-01